Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)

Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)

Recent success of novel therapies has improved treatment of chronic lymphocytic leukemia (CLL) patients, but most of them still require several treatment regimes. To improve treatment choice, prognostic markers suitable for prediction of disease outcome are required. Several molecular/genetic marker...

Full description

Bibliographic Details
Main Authors:	Kübra Kaban, Sarah M. Greiner, Samuel Holzmayer, Claudia Tandler, Sophie Meyer, Clemens Hinterleitner, Helmut R. Salih, Melanie Märklin, Jonas S. Heitmann
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Diagnostics
Subjects:	CLL 4-1BB/4-1BBL GITR/GITRL survival
Online Access:	https://www.mdpi.com/2075-4418/11/11/2041

Similar Items

The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses
by: Isabel eBarao
Published: (2013-01-01)

Soluble glucocorticoid-induced tumor necrosis factor receptor regulates Helios expression in myasthenia gravis
by: Yi Li, et al.
Published: (2019-05-01)

MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential
by: Natalie J. Tigue, et al.
Published: (2017-03-01)

GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memory
by: Nick M. Durham, et al.
Published: (2017-06-01)

Fundamental Characterization of Antibody Fusion-Single-Chain TNF Recombinant Proteins Directed against Costimulatory TNF Receptors Expressed by T-Lymphocytes
by: Hodaka Nagai, et al.
Published: (2023-06-01)

Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for T cell activation
by: Min Zhao, et al.
Published: (2021-09-01)

The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity
by: Yuan He, et al.
Published: (2022-01-01)

Anti‐CLL1‐based CAR T‐cells with 4‐1‐BB or CD28/CD27 stimulatory domains in treating childhood refractory/relapsed acute myeloid leukemia
by: Kunlin Pei, et al.
Published: (2023-04-01)

Контрольные точки в контексте наружного генитального эндометриоза.
by: Anastasia Sergeevna Belevich, et al.
Published: (2019-08-01)

The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy
by: Christina Claus, et al.
Published: (2023-12-01)

Low-Dose LPS Induces Tolerogenic Treg Skewing in Asthma
by: Fengxia Ding, et al.
Published: (2020-09-01)

Anti-CD166/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma
by: Yitian Wang, et al.
Published: (2019-04-01)

An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer
by: Dinh-Toi Chu, et al.
Published: (2019-04-01)

Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients
by: Jiayi Yu, et al.
Published: (2018-01-01)

Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth
by: Martin R. Ramos-Gonzalez, et al.
Published: (2024-03-01)

Accelerating Cancer Immunotherapy Through 4-1BB Activation
by: Todd eBartkowiak, et al.
Published: (2015-06-01)

<i>N</i>-Glycosylation Facilitates 4-1BB Membrane Localization by Avoiding Its Multimerization
by: Ruoxuan Sun, et al.
Published: (2022-01-01)

Targeting 4-1BB for tumor immunotherapy from bench to bedside
by: Ya-Tao Wang, et al.
Published: (2022-09-01)

4-1BB: A promising target for cancer immunotherapy
by: Alyssa Min Jung Kim, et al.
Published: (2022-09-01)

The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation
by: Gerard J. Chu, et al.
Published: (2023-12-01)

An Oncolytic Adenovirus Encoding SA-4-1BBL Adjuvant Fused to HPV-16 E7 Antigen Produces a Specific Antitumor Effect in a Cancer Mouse Model
by: Alejandra G. Martinez-Perez, et al.
Published: (2021-02-01)

4-1BBL as a Mediator of Cross-Talk between Innate, Adaptive, and Regulatory Immunity against Cancer
by: Alejandra G. Martinez-Perez, et al.
Published: (2021-06-01)

PD-1 and beyond to Activate T Cells in Cutaneous Squamous Cell Cancers: The Case for 4-1BB and VISTA Antibodies in Combination Therapy
by: Quentin Wright, et al.
Published: (2021-07-01)

Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB
by: Morten Aagaard Nielsen, et al.
Published: (2022-06-01)

OCULAR INJURIES CAUSED BY BB GUN
by: M.S. Farahvash
Published: (1999-08-01)

OCULAR INJURIES CAUSED BY BB GUN
by: M.S. Farahvash
Published: (1999-09-01)

Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent
by: Diogo Gomes-Silva, et al.
Published: (2017-10-01)

Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes
by: Elisa Claeys, et al.
Published: (2021-04-01)

Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications
by: Shahram Salek-Ardakani, et al.
Published: (2023-08-01)

Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens
by: Yuan eZhao, et al.
Published: (2012-11-01)

Recombinant Costimulatory Fusion Proteins as Functional Immunomodulators Enhance Antitumor Activity in Murine B16F10 Melanoma
by: Huaman Cai, et al.
Published: (2020-05-01)

Correlation of 4-1BBL+ B Cells in Tumor Draining Lymph Nodes with Pathological Characteristics of Breast Cancer
by: Mohsen Arabpour, et al.
Published: (2019-06-01)

Hu.4-1BB-Fc fusion protein inhibits allergic inflammation and airway hyperresponsiveness in a murine model of asthma
by: Byoung-Ju Kim, et al.
Published: (2011-09-01)

The Zinc Finger Transcription Factor BbCmr1 Regulates Conidium Maturation in Beauveria bassiana
by: Jin-Feng Chen, et al.
Published: (2022-02-01)

EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells
by: Christopher J. Stairiker, et al.
Published: (2021-11-01)

4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells
by: Qiang Dai, et al.
Published: (2020-11-01)

BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production
by: Lidia Karabon, et al.
Published: (2021-11-01)

Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4
by: Alaa Alsalloum, et al.
Published: (2023-10-01)

Immunotherapy with 4-1BBL-Expressing iPS Cell‐Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma
by: Haruka Kuriyama, et al.
Published: (2021-02-01)

Construction of a recombinant adenovirus co-expressing truncated human prostate-specific membrane antigen and mouse 4-1BBL genes and its effect on dendritic cells
by: Xiaodong Weng, et al.
Published: (2011-03-01)